Expanding healthcare with eye tracking

Summary

The correlation between eye movement and performance — which is critical for elite and professional athletes — is a well-researched subject. However, manual observation of eye movement is subjective and lacks systematic measurement. Eye tracking helps overcome these issues by providing robust measurements for a wide population range in real-life scenarios as well as lab situations. 

But data isn’t that much use if you can’t present it in a way that is relevant to the user, such as a coach, a doctor, or a therapist searching for ways to solve an issue or understand why a person is performing well or not. By combining Tobii’s accurate and stable technology with the results of scientific research and turning it into a commercial solution, RightEye has brought a life-changing product to the healthcare market. 

In this success story, we cover the collaboration between Tobii and RightEye and how within six months of meeting in mid-2017, we brought a solution to the market that received FDA clearance in October 2018. 

About RightEye 

US company RightEye has commercialized an easy-to-use eye tracking solution that helps healthcare professionals and performance specialists provide innovative care to their patients and clients. RightEye has combined its cloud-based software solution with an adapted medical-grade, eye tracking tablet from Tobii to make the correlation between eye movements and health more accessible for doctors, therapists, educators, and athletic performance professionals across the United States. 

In 2012, co-founders Melissa Hunfalvay and Adam Gross met on the tennis court. A former professional athlete and an accomplished human performance researcher, Hunfalvay discussed with Gross about how she had been using eye tracking to help improve the skills of professional athletes. Her ultimate pain point with the methodology was the time it took to process and analyze the data from the eye trackers. A serial entrepreneur, Gross saw this issue as an opportunity to create an innovative solution that could work on a broad scale.